Call it the extreme corporate makeover. While some companies embrace their past, others want people to forget what they’ve done. It’s a strategy that seems to work well for biotechnology companies that have lost too much money, angered too many investors, or gone too long without delivering a product.For example: Boston Life Sciences Inc.
